title: Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
abstract: Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease characterized histologically by nonsuppurative destructive cholangitis. Sera from patients with PBC react with a series of intramitochondrial enzymes with the immunodominant response directed against the E2 component of the pyruvate dehydrogenase complex (PDC-E2). Recently, using tissue sections of late-stage PBC, we showed that there is increased expression in biliary epithelial cells of patients with PDC-E2 or a molecule cross-reactive with PDC-E2. Previous work has shown that biliary epithelial cells of patients with PBC express an increased amount of class II. To address the sequence of events in the evolution of PBC, we have focused our attention in this study on early biliary epithelial lesions. In particular, we have studied the liver of 22 female patients with PBC that was diagnosed as either stage I or stage II using both a mouse monoclonal antibody that has reactivity similar to human autoantibodies as well as a human Fab combinatorial prepared from the lymph node of a PBC patient. Tissues were simultaneously stained using antibodies to PDC-E2, class II, and BB1/B7. As a positive control, tissues from late-stage PBC were studied concurrently. By determining the order of expression among the three molecules, PDC-E2, class II, and BB1/B7, we report that the expression of PDC-E2 or a PDC-E2-like molecule on biliary duct epithelium of patients with PBC precedes the expression of BB1/B7 and major histocompatibility complex (MHC) class II molecules. The alteration of an autoantigen in biliary duct epithelium may be the earliest lesion in PBC.
authors.affiliation: Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616, USA.
authors.forename: K
authors.initials: K
authors.lastname: Tsuneyama
authors.forename: J
authors.initials: J
authors.lastname: Van de Water
authors.forename: P S
authors.initials: PS
authors.lastname: Leung
authors.forename: S
authors.initials: S
authors.lastname: Cha
authors.forename: Y
authors.initials: Y
authors.lastname: Nakanuma
authors.forename: M
authors.initials: M
authors.lastname: Kaplan
authors.forename: R
authors.initials: R
authors.lastname: De Lellis
authors.forename: R
authors.initials: R
authors.lastname: Coppel
authors.forename: A
authors.initials: A
authors.lastname: Ansari
authors.forename: M E
authors.initials: ME
authors.lastname: Gershwin
mesh_terms: D000328:Adult; D000818:Animals; D018122:B7-1 Antigen / Q000032:analysis*; D001652:Bile Ducts / Q000201:enzymology / Q000276:immunology*; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D005260:Female; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D008105:Liver Cirrhosis, Biliary / Q000201:enzymology / Q000276:immunology*; D051379:Mice; D008875:Middle Aged; D011768:Pyruvate Dehydrogenase Complex / Q000032:analysis* / Q000276:immunology
chemical_list: D018122:B7-1 Antigen; D006684:HLA-DR Antigens; D007070:Immunoglobulin A; D011768:Pyruvate Dehydrogenase Complex; D051047:Dihydrolipoyllysine-Residue Acetyltransferase